Berger Franklin M Insider Trades

Insider Trading History

Track insider trading activity for Berger Franklin M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $0 0 shares
Last Trade
May 11, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$620k 89,069 shares
$6.96
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $0 0 shares
Last Trade
May 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$19k 2,600 shares
$7.29
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $0 0 shares
Last Trade
May 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$36.5k 5,000 shares
$7.29
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $0 0 shares
Last Trade
May 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$25.5k 3,500 shares
$7.29
$7.29
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $0 0 shares
Last Trade
May 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$33.5k 5,000 shares
$6.70
$7.29
Essa Pharma
Essa Pharma EPIX
Director
Holding Value $0 0 shares
Last Trade
Oct 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$158k 784,404 shares
$0.20
$0.20
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $185k 41,200 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$134k 41,200 shares
$3.25
$4.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $2.27M 506,497 shares
Last Trade
Jun 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 29,600 shares
$3.25
$4.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $0 0 shares
Last Trade
Jun 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 29,600 shares
$3.25
$4.48
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $36.5k 5,000 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.3k 5,000 shares
$4.46
$7.29
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $2.14M 476,897 shares
Last Trade
Jan 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.6k 10,000 shares
$3.36
$4.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $2.14M 476,897 shares
Last Trade
Jan 16, 2025 Sale (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$33.6k 10,000 shares
$3.36
$4.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $2.09M 466,897 shares
Last Trade
Jan 15, 2025 Sale (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$47.9k 15,000 shares
$3.19
$4.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $2.09M 466,897 shares
Last Trade
Jan 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$47.9k 15,000 shares
$3.19
$4.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $2.02M 451,897 shares
Last Trade
Dec 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.02M 359,606 shares
$2.85
$4.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $185k 41,200 shares
Last Trade
Jun 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 41,200 shares
$3.44
$4.48
Kezar Life Sciences
Kezar Life Sciences KZR
Director
Holding Value $365k 50,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$331k 50,000 shares
$6.62
$7.29
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $0 0 shares
Last Trade
Jun 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$120k 33,150 shares
$3.61
$4.48
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Director
Holding Value $3.64M 811,503 shares
Last Trade
Jun 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$120k 33,150 shares
$3.61
$4.48
Essa Pharma
Essa Pharma EPIX
Director
Holding Value $10.1k 50,000 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$452k 50,000 shares
$9.04
$0.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up